Congressmen: This Covid hearing ‘could have been an email’
WASHINGTON — House Republicans have repeatedly accused Biden health officials of withholding and censoring documents…
Category: research
Pfizer’s reset year starts with a little profit
Want to stay on top of the science and politics driving biotech today? Sign up to get…
How an immunological Trojan horse could treat disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Scientists document first-ever transmitted Alzheimer’s cases, tied to no-longer-used medical procedure
LONDON — There was something odd about these Alzheimer’s cases. Part of it was the…
23andMe breach targeted Chinese, Jewish populations
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity
PONTYPRIDD, Wales — The blog post that has shaken the leadership of Boston’s Dana-Farber Cancer…
.jpg)
Eli Lilly overtakes Tesla in market value
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Two genomics powerhouses team up to expand infectious disease surveillance
LONDON — Two research centers that have been at the forefront of following the evolution…
Another step toward new drugs for Parkinson’s
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Osteoarthritis might be linked to protein known for its role in Alzheimer’s, study says
A kind of protein implicated in Alzheimer’s disease might also contribute to the breakdown of…
New chronic Covid study offers insight into which immunocompromised patients are most at risk
You’ve heard of long Covid, a condition in which the acute infection subsides but troubling…
Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
As NIH grant runs out, Dog Aging Project founders look to raise up to $50 million
The Dog Aging Project, which researchers say could yield promising leads for human longevity research,…
Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Dana-Farber expands studies to be retracted to 6, plus 31 to be corrected over mishandled data
A review of alleged data manipulation in studies involving four top scientists at Dana-Farber Cancer…
New tool for tracing blood cells’ ancestry might one day help predict disease risk
The human blood system is in a constant state of turnover. First-line immune defenders, like…
Investigators fault Lilly plant for manufacturing issues
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Dana-Farber cancer researchers moving to retract one paper, correct others in broad investigation of manipulated data
Scientists at Dana-Farber Cancer Institute, one of the nation’s leading cancer research and treatment centers,…
.jpg)
The Senate health committee looks into its first subpoena in 40 years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Could long Covid’s signs of immune dysregulation in the blood lead to a diagnostic test?
Long Covid has long eluded scientists looking for its cause. Not knowing what triggers its…
STAT+: CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say
For three days in December, an ICU room at the Hospital of the University of…
The XBI comedown after JPM
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Testosterone didn’t lower fracture risk in a surprising new study. Researchers have theories about why
Testosterone is essential for bone health in men. It helps maintain bone density and improve…
The big any-day-now biotech news we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A new, non-invasive test could help predict the quality of embryo used for IVF
Researchers from the University of California San Diego School of Medicine say a new method…
STAT+: Hair loss is one of the most hated chemotherapy side effects. A new biotech hopes to prevent it
The chemotherapy Christine Ko was prescribed for her breast cancer is pretty much a guarantee…
STAT+: Survey: Confusion over key requirements means clinical trials aren’t registered and results aren’t reported
More than half of those responsible for registering clinical trials and reporting results fail to…
The four biotech stories you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: The new NIH director is walking a tightrope on Biden’s drug pricing vision
WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally…
STAT+: For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery
A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical…
The highs — and lows — of JPM 2024 you should pay attention to
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
After grilling Fauci on Covid origins, House Republicans want to consider new rules for foreign research
WASHINGTON — House Republicans want to explore tighter inspection and safety requirements for infectious disease…
Nearly 1 in 10 global teens have used “budget Ozempic” laxatives and other risky weight-loss products, per study
New weight loss medications like Ozempic and Wegovy have garnered a lot of attention in…
JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
This is the TLDR of JPM Day 1
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
Baby monitor videos yield evidence for long-suspected link between seizures and unexplained toddler deaths
The baby monitor didn’t go off. Any sound or motion in the twins’ room was…
Why CG Oncology will be the first test of 2024’s IPO waters
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Renamed, common liver diseases might get fairer shake at treatment, researchers hope
A slate of liver diseases got a rebrand this year. Experts hope the change can…
Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis
Reducing or eliminating alcohol consumption reduces the risk of developing oral cavity and esophagus cancers,…
STAT+: What comes after Wegovy? The quest to eradicate obesity
About a decade ago, after becoming obese, Jacob Petersen lost weight so quickly that some…
STAT+: New weight loss drugs have proven their effectiveness. Now researchers want to know how to best use them
LONDON — Starting in the new year, a team of researchers in the U.K. and…
Morning Rounds: Our newsroom’s favorite stories of 2023
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
The clock is ticking, and cytokinetics is running out of December
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Why health care costs are nearly a fifth of the GDP
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
BioMarin appeases an activist
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Americans put faith in nurses as overall confidence in health care ebbs
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
The biotech updates you need to read today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Structure Therapeutics GLP-1 pill cuts blood sugar, weight in early diabetes study
Structure Therapeutics said Monday that its experimental GLP-1 pill demonstrated a 1% lowering of blood…
Morning Rounds: Americans’ health is trending downward, poll finds
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
FDA chastens pet companies over antibiotics
Want to stay on top of the science and politics driving biotech today? Sign up to get…